Abstract
幼年型粒单核细胞白血病（JMML）是一种罕见的儿童早期恶性克隆性疾病，2022年世界卫生组织公布的第5版血淋巴肿瘤分类已将其归入骨髓增殖性肿瘤（MPN）。近年来，JMML的多组学研究不断取得进展，使JMML的临床分型得以补充、分子特征被逐步认识，这有助于疾病的诊断和危险度分层，进而根据不同危险度制定更加合理的临床决策，现对JMML的分子特征及诊疗进展进行综述。.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua er ke za zhi = Chinese journal of pediatrics
Paper Title
Journal
Date
